Sciwind Biosciences to present Data from its GLP-1 and GIP Receptor Agonist Programs at The International Liver Congress(TM) EASL 2022

/PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat...

Related Keywords

China ,United Kingdom ,Hangzhou ,Zhejiang ,London ,City Of ,Xinle Wu ,Sciwind Biosciences Co Ltd ,International Liver Congress ,International Liver ,Annual Meeting ,European Association ,Chief Scientific Officer ,Saturday June ,Hangzhou Sciwind Biosciences Co ,Td ,